RiteMed defines its mission as making quality, affordable medicines accessible to Filipino households, emphasizing that cost-effectiveness should not come at the expense of product standards.

Foundation in 2002

RiteMed was established in 2002 by United Laboratories (Unilab) during a period when the Philippine government actively encouraged the pharmaceutical industry to lower the cost of essential medicines.[1] Unilab leadership sought to address this challenge through a non-traditional approach. Rather than marketing numerous individual product brands, the company created a single, recognizable identity for generic medicines.[1] This “unibranded” model was designed to reduce marketing expenditures, allowing savings to be passed on to consumers while simultaneously building trust among both healthcare professionals and the general public.

Upon launch, RiteMed offered approximately 20 essential medicines at prices reportedly 20–70% lower than equivalent branded products.[2] This entry into the market was significant because generic medicines in the Philippines were frequently perceived as inferior or intended solely for low-income consumers. Consequently, RiteMed had to market not only its products but also the concept that generic medicines could be a trusted, quality choice.

Early expansion

Between 2002 and 2010, RiteMed expanded its portfolio beyond its initial lineup of antibiotics, vitamins, and pain relievers to include treatments for cardiovascular, respiratory, and allergy-related conditions. The company’s early growth strategy relied heavily on cultivating relationships with physicians and healthcare professionals to encourage confidence in prescribing RiteMed products.

The 2009–2010 challenge

The brand faced a significant business crisis following the Philippine government’s implementation of the Maximum Drug Retail Price (MDRP) in 2009 and price reductions under the Government-Mediated Access Price (GMAP) program. As regulatory pressure forced industry-wide price cuts, RiteMed’s competitive advantage eroded. The company recorded substantial financial losses in 2010 and subsequently transferred many medical representatives to other Unilab divisions. This crisis necessitated a fundamental shift in the company’s business model.

Moving away from conventional physician-centric marketing, RiteMed repositioned itself as an advocacy-oriented consumer brand centered on the message that quality medicine need not be expensive. The company launched the “Bawal ang Mahal” campaign featuring actress Susan Roces as brand ambassador.[1] This initiative challenged the prevailing perception that inexpensive medicines were inherently inferior.

This pivot represented a major departure in Philippine pharmaceutical marketing. Instead of focusing exclusively on prescribers, RiteMed began empowering patients and consumers to recognize their right to ask for affordable alternatives. The resulting increase in consumer awareness and trust encouraged drugstore chains to expand their stocking of RiteMed products.

RiteMed’s identity is closely tied to public-facing campaigns promoting health access and affordability:

• “Bawal ang Mahal”: A defining campaign asserting that quality healthcare does not require expensive medicines.[1]
• “May Karapatan Kang Gumaling” (“You have the right to get well”): Reinforced the principle that access to appropriate healthcare is a right rather than a privilege.
• “Gusto Naming Gumaling Kayo” (“We want you to get well”): Continued the brand’s patient-oriented positioning.
• “Dasal Naming Gumaling Kayo” (“We pray that you get well”): Maintained an emotional, culturally resonant tone in brand communications.
• “Huwag Mahihiyang Magtanong” (“Don’t be shy to ask”): Launched in 2015 to address hesitation among lower-income consumers about requesting cheaper alternatives. The campaign encouraged active inquiry regarding affordable options and reportedly influenced subsequent communication strategies.

Later campaigns included “Tiwala,” “Di Dapat Mahal ang Magmahal,” and “Pag may check, that’s the right one!”

Understanding RiteMed requires distinguishing its approach from traditional pharmaceutical branding. While a generic name refers to an active ingredient (e.g., paracetamol, losartan), companies typically sell these under distinct brand names. RiteMed instead established a single corporate identity across multiple generic categories.[1] This allowed the company to invest in building trust in the RiteMed name itself rather than fragmenting resources across dozens of individual labels.

• Traditional model: Many individual brands → individual marketing → higher promotional costs.
• RiteMed model: One trusted generic identity → broader portfolio → efficient brand-building → emphasis on affordability.

This unibranded structure remains a core component of RiteMed’s competitive identity.[1]

RiteMed’s portfolio has grown significantly since its inception to include both prescription and OTC medicines, vitamins, and household healthcare products. Therapeutic areas covered include:

• Antibiotics
• Pain and fever management
• Vitamins and nutritional supplements
• Cardiovascular health
• Respiratory care
• Anti-allergy treatments
• Chronic disease management
• Household remedies (e.g., povidone-iodine, isopropyl alcohol)

Unilab describes RiteMed as offering a diversified range of OTC and prescription products alongside vitamins and household essentials.

RiteMed’s value proposition rests on three pillars:

1. Quality: Products are manufactured under strict standards to ensure safety and efficacy.
2. Affordability: The business model is structured to minimize cost barriers to essential medicines.
3. Accessibility: Advocacy efforts aim to improve physical availability and consumer knowledge regarding generics.

The company summarizes its corporate thrust as Quality + Affordability + Accessibility.

RiteMed is an integral part of the Unilab Group, one of the largest pharmaceutical and healthcare organizations in the Philippines. Within the group’s structure, RiteMed operates as the “Unibranded Pharma Company” alongside Unilab’s conventional pharmaceutical division and UL Skin Sciences.[1] It was created by Unilab and remains fully integrated into the wider enterprise, which provides healthcare, wellness, and personal care products across Southeast Asia.

RiteMed is positioned not as a premium brand but as a facilitator of financial access to reliable medicine. Its communications consistently encourage consumers to know generic names, ask professionals about affordable alternatives, and view accessible healthcare as a right. This dual identity as both a pharmaceutical manufacturer and a healthcare-access advocate distinguishes it in the local market.

Beyond advertising, RiteMed supports access through initiatives such as the RiteCare Program, launched circa 2012 to bring affordable medicines closer to homes and workplaces. The brand also participates in medical missions and community outreach, including donations of maintenance medicines worth ₱1.1 million to senior citizens in Manila.

The name RiteMed directly reflects the proposition “Right Medicine, Priced Right,” combining “Rite” (correct/appropriate) with “MED” (medicine). Visually, the brand utilizes a check mark symbol to reinforce the concept of making the correct, trusted choice.

Since its 2002 launch, RiteMed has played a role in shifting perceptions of generic medicines in the Philippines. By establishing a trusted unibranded identity, it helped transform affordability from a marker of low quality into a consumer-rights issue. This positioning differentiated RiteMed from competitors focused solely on individual product promotion and helped normalize the use of generics across socioeconomic segments.

More than two decades after its founding, RiteMed continues to operate as a leading provider of affordable medicines in the Philippines. Its current portfolio spans prescription drugs, OTC products, and vitamins, supported by ongoing professional engagement and community health advocacy.[1] Recent activities include participation in medical conventions and partnerships with public figures to promote healthcare access.

1. RiteMED History
2. RITEMED